Evidence map›Paper›PMID 24406291›Full record

ReviewGynecologic oncology2014

Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Yvonne Collins, Kevin Holcomb, Eloise Chapman-Davis, Dineo Khabele, John H Farley

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gynecologic oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Diminishing Returns Among Black Patients With Cancer: The Intersection of Race and Neighborhood Socioeconomic Status.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  8. Observational
  9. Article
  10. Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yvonne CollinsDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA. Electronic address: yvonneccollins@gmail.com.
Kevin HolcombDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College at New York-Presbyterian Hospital, New York, NY 10065, USA.
Eloise Chapman-DavisDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Tufts University Medical Center, Boston, MA 02118, USA.
Dineo KhabeleDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
John H FarleyDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arizona Cancer Center, Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.

Funding

Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian CancerK08CA148887 · NCI · VANDERBILT UNIVERSITY · PI KHABELE, DINEO · 2010 to 2014
$795k
NCI NIH HHS K08 CA148887
6 · The paper itself

Abstract

objectivesTo review the extent of health disparities in gynecologic cancer care and outcomes and to propose recommendations to help counteract the disparities.

methodsWe searched the electronic databases PubMed and the Cochrane Library. We included studies demonstrating quantifiable differences by race and ethnicity in the incidence, treatment, and survival of gynecologic cancers in the United States (US). Most studies relied on retrospective data. We focused on differences between Black and White women, because of the limited number of studies on non-Black women.

resultsWhite women have a higher incidence of ovarian cancer compared to Black women. However, the all-cause ovarian cancer mortality in Black women is 1.3 times higher than that of White women. Endometrial and cervical cancer mortality in Black women is twice that of White women. The etiology of these disparities is multifaceted. However, much of the evidence suggests that equal care leads to equal outcomes for Black women diagnosed with gynecologic cancers. Underlying molecular factors may play an additional role in aggressive tumor biology and endometrial cancer disparities.

conclusionGynecologic cancer disparities exist between Black and White women. The literature is limited by the lack of large prospective trials and adequate numbers of non-Black racial and ethnic groups. We conclude with recommendations for continued research and a multifaceted approach to eliminate gynecologic cancer disparities.

Indexed as

Advisory CommitteesHealthcare DisparitiesHealth Status DisparitiesBlack or African AmericanFemaleGenital Neoplasms, FemaleHumansUnited StatesWhite PeopleCervicalDisparitiesEndometrial and ovarian cancersEthnicGynecologic cancerRacial

Identifiers

PMID24406291
PMCPMC4079541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.